Cyclerion Therapeutics, Inc.
sGC stimulators

Abstract:

The present patent application discloses at least the compounds according to Formula I' shown below, or pharmaceutically acceptable salts thereof, ##STR00001## wherein ring D, ring A, ring E, J.sup.B, n, J.sup.D, J, X, Z, Z.sup.1, R.sup.C1, R.sup.C2, Y, R.sup.9, o and W are as defined herein.